Airway Management Devices

Global Airway Management Devices Market to Reach US$2.8 Billion by 2030

The global market for Airway Management Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Resuscitators, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$890.9 Million by the end of the analysis period. Growth in the Infraglottic Devices segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$622.5 Million While China is Forecast to Grow at 7.0% CAGR

The Airway Management Devices market in the U.S. is estimated at US$622.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$329.3 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Airway Management Devices Market - Key Trends & Drivers Summarized

Airway management devices are essential tools in medical practice, designed to maintain or restore ventilation in patients during surgical procedures, emergencies, and intensive care. These devices include a range of products such as endotracheal tubes, laryngeal mask airways, tracheostomy tubes, and ventilators, among others. They are used to ensure that the airway remains open and that gases such as oxygen and carbon dioxide can be exchanged effectively. This field has seen significant technological advancements aimed at improving patient safety and outcomes, including the development of devices that minimize the risk of trauma or infection, and provide real-time data on patient status.

Market trends in airway management devices indicate a robust growth trajectory, influenced by several factors including rising incidences of respiratory diseases, an aging global population, and increasing healthcare expenditures. The prevalence of chronic respiratory diseases such as asthma, COPD (Chronic Obstructive Pulmonary Disease), and obstructive sleep apnea has led to a higher demand for advanced airway management solutions in both emergency and routine medical procedures. Furthermore, the COVID-19 pandemic significantly underscored the critical nature of effective airway management, leading to an unprecedented surge in the deployment of ventilators and other respiratory support technologies in hospitals around the world. The market is also witnessing a shift towards the use of disposable airway management devices to reduce the risk of cross-contamination—a trend that has been accelerated by the global pandemic.

The growth in the airway management devices market is driven by several factors, including technological innovations, regulatory policies, and demographic changes. Advanced materials and design improvements that enhance the safety and comfort of airway devices are pivotal in driving adoption rates. For example, the integration of sensors and connectivity features allows for continuous monitoring and data analytics, enhancing decision-making in critical care settings. Regulatory environments in major markets have also evolved, with stricter guidelines boosting the demand for devices that meet higher safety and efficacy standards. Additionally, the growing geriatric population, which is more prone to respiratory ailments, and the expansion of healthcare infrastructure in emerging economies are further stimulating market expansion.

SCOPE OF STUDY:

The report analyzes the Airway Management Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Segment (Resuscitators, Infraglottic Devices, Supraglottic Devices, Other Product Segments); Application (Anesthesia, Emergency Medicine, Other Applications); End-Use (Hospitals, Home Care, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 144 Featured) -

• Ambu, Inc.
• Acutronic Medical Systems AG
• Airway Management
• Airways Surgical Pvt., Ltd.
• Angiplast Pvt., Ltd.
• Armstrong Medical Ltd.
• ASID BONZ GmbH
• Besmed Health Business Corporation
• BLS Systems Ltd.
• Asia Connection Co., Ltd.
• Bactiguard
• Avanos Medical, Inc.
• AUG Medical
• Biovo
• Bell Medical, Inc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.